BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 7060571)

  • 1. The nature of the binding for prothrombinase at the platelet surface as revealed by lipolytic enzymes.
    Bevers EM; Comfurius P; Zwaal RF
    Eur J Biochem; 1982 Feb; 122(1):81-5. PubMed ID: 7060571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet prothrombinase in health and disease.
    Crook M
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):167-74. PubMed ID: 2130928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The platelet cytoskeleton contains elements of the prothrombinase complex.
    Tuszynski GP; Mauco GP; Koshy A; Schick PK; Walsh PN
    J Biol Chem; 1984 Jun; 259(11):6947-51. PubMed ID: 6539331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of procoagulant binding sites on the platelet surface.
    Bevers EM; Rosing J; Zwaal RF
    Adv Exp Med Biol; 1985; 192():359-71. PubMed ID: 3914834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived microvesicles and activated platelets express factor Xa activity.
    Holme PA; Brosstad F; Solum NO
    Blood Coagul Fibrinolysis; 1995 Jun; 6(4):302-10. PubMed ID: 7548677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet procoagulant properties studied with snake venom prothrombin activators.
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    Thromb Haemost; 1987 Jun; 57(3):349-55. PubMed ID: 3310319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet membrane involvement in blood coagulation.
    Hemker HC; van Rijn JL; Rosing J; van Dieijen G; Bevers EM; Zwaal RF
    Blood Cells; 1983; 9(2):303-17. PubMed ID: 6661560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acceleration of the inhibition of platelet prothrombinase complex by heparin.
    Ellis V; Scully MF; Kakkar VV
    Biochem J; 1986 Jan; 233(1):161-5. PubMed ID: 3954724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V: a platelet cytoskeletal associated protein.
    Tuszynski GP; Walsh PN
    Haematologia (Budap); 1984; 17(1):67-76. PubMed ID: 6427071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin.
    Bevers EM; Karniguian A; Legrand YJ; Zwaal RF
    Thromb Res; 1985 Feb; 37(3):365-70. PubMed ID: 3922080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of activated human platelets in prothrombin and factor X activation.
    Rosing J; van Rijn JL; Bevers EM; van Dieijen G; Comfurius P; Zwaal RF
    Blood; 1985 Feb; 65(2):319-32. PubMed ID: 3967085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of platelet prothrombinase activity by prostacyclin.
    Zwaal RF; Comfurius P; Hemker HC; Bevers EM
    Haemostasis; 1984; 14(4):320-4. PubMed ID: 6094319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor Xa dimerization competes with prothrombinase complex formation on platelet-like membrane surfaces.
    Koklic T; Chattopadhyay R; Majumder R; Lentz BR
    Biochem J; 2015 Apr; 467(1):37-46. PubMed ID: 25572019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired factor X and prothrombin activation associated with decreased phospholipid exposure in platelets from a patient with a bleeding disorder.
    Rosing J; Bevers EM; Comfurius P; Hemker HC; van Dieijen G; Weiss HJ; Zwaal RF
    Blood; 1985 Jun; 65(6):1557-61. PubMed ID: 3995186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bothrojaracin, a proexosite I ligand, inhibits factor Va-accelerated prothrombin activation.
    Monteiro RQ; Zingali RB
    Thromb Haemost; 2002 Feb; 87(2):288-93. PubMed ID: 11858489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated protein C inhibits platelet prothrombin-converting activity.
    Comp PC; Esmon CT
    Blood; 1979 Dec; 54(6):1272-81. PubMed ID: 508937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced prothrombin-converting activity and factor Xa binding of platelets activated by the alternative complement pathway.
    Ozge-Anwar AH; Freedman JJ; Senyi AF; Cerskus AL; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):221-8. PubMed ID: 6610438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the abilities of synthetic and platelet-derived membranes to enhance thrombin formation.
    Jones ME; Lentz BR; Dombrose FA; Sandberg H
    Thromb Res; 1985 Sep; 39(6):711-24. PubMed ID: 4082107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A binding site expressed on the surface of activated human platelets is shared by factor X and prothrombin.
    Scandura JM; Ahmad SS; Walsh PN
    Biochemistry; 1996 Jul; 35(27):8890-902. PubMed ID: 8688425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of the prothrombinase complex on lipid vesicles depends on the stereochemical configuration of the polar headgroup of phosphatidylserine.
    Comfurius P; Smeets EF; Willems GM; Bevers EM; Zwaal RF
    Biochemistry; 1994 Aug; 33(34):10319-24. PubMed ID: 8068668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.